Hetero-oligomerization with CXCR4 induces negative binding cooperativity—CXCL12 binding to CXCR4 suppresses CXCL11-mediated CXCR3 activation, a mechanism implicated in tumor immune evasion (Watts et al., 2013). The gene discussed is CXCL11; the disease is neoplasm.